U.S. markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.07%)
     
  • BTC-USD

    35,977.19
    +112.68 (+0.31%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Global Psoriasis Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

·2 min read

The "Global Psoriasis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Psoriasis Epidemiology and Patient Flow Analysis - 2021, provides Psoriasis epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Psoriasis patients, history of the disease at the population level (Psoriasis prevalence, Psoriasis incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Psoriasis patient flow: Psoriasis prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Psoriasis patients by age group, gender

  • Forecast: Psoriasis epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Psoriasis market sizing, assessing market potential, and developing drug forecast models

  • Identify Psoriasis patients segments through age groups, gender, and disease sub-types

  • Develop Psoriasis population-based health management frameworks

  • Evaluate Psoriasis market opportunities, identify target patient population

  • Align marketing decisions with the Psoriasis target population

  • Communicate leadership and health authorities about your Psoriasis target patient population

Key Topics Covered:

1. Research Methodology

2. Psoriasis Patients Definition

3. US Psoriasis Epidemiology and Patient Flow

4. Germany Psoriasis Epidemiology and Patient Flow

5. France Psoriasis Epidemiology and Patient Flow

6. Italy Psoriasis Epidemiology and Patient Flow

7. Spain Psoriasis Epidemiology and Patient Flow

8. UK Psoriasis Epidemiology and Patient Flow

9. Europe Psoriasis Epidemiology and Patient Flow

10. Japan Psoriasis Epidemiology and Patient Flow

11. Global Psoriasis Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/c63dph

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005564/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900